Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline for Body Weight and Glucose Tolerance in Healthy Obese Adults
NCT01395602Phase 2Completed
- Sponsor
- Columbia University
- Start
- Apr 2002
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabergoline in obesity, impaired glucose tolerance (IGT), sponsored by Columbia University. Started Apr 2002; status: completed.
02
Drugs
cabergoline
03
Conditions
obesityimpaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT01395602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01395602.